These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice]. Olsson AG; Nilsson PM Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786 [No Abstract] [Full Text] [Related]
16. Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study. Pauriah M; Struthers AD; Lang CC Cardiovasc Ther; 2008; 26(2):85-8. PubMed ID: 18485130 [No Abstract] [Full Text] [Related]
17. [Persistent CK-elevation after CSE inhibitor therapy]. Faehling M; Leschke M Dtsch Med Wochenschr; 2006 Aug; 131(33):1827-8. PubMed ID: 16902911 [No Abstract] [Full Text] [Related]
18. Is it over for ezetimibe? Robinson JG; Davidson M Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):781-3. PubMed ID: 18570614 [No Abstract] [Full Text] [Related]
19. Long-term follow-up of the West of Scotland Coronary Prevention Study. Tsubokura M; Kami M N Engl J Med; 2008 Jan; 358(2):193-4; author reply 194-5. PubMed ID: 18193526 [No Abstract] [Full Text] [Related]
20. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Almutairi F; Peterson TC; Molinari M; Walsh MJ; Alwayn I; Peltekian KM Liver Transpl; 2009 May; 15(5):504-8. PubMed ID: 19399742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]